Client · LDA

FERRING PHARMACEUTICALS, INC.

5 filings 12 bills mentioned 1 registrants 5 quarters ~$990,000 reported

Client ID

200739

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

HR 1878

IVF Access and Affordability Act

TAX

5

HR 4639

Infertility Treatment Affordability Act of 2025

TAX

3

HR 220

Veterans Infertility Treatment Act of 2025

HCR

3

S 797

Family Building FEHB Fairness Act

HCR

3

HR 1670

Family Building FEHB Fairness Act

HCR

3

HR 3838

Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026

HCR

2

HR 4299

Protecting Patient Access to Cancer and Complex Therapies Act

HCR

2

S 2296

National Defense Authorization Act for Fiscal Year 2026

HCR

2

HR 8119

HOPE with Fertility Services Act

HCR

1

HCONRES 14

Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.

HCRTAX

1

HR 6797

Bipartisan IVF for Military Families Act

HCR

1

HR 1

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

HCRTAX

1

Registrants

Lobbying firms that filed on behalf of this client.

FERRING PHARMACEUTICALS, INC. 5

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.